Lung cancer (LC) is the most common cancer-related death globally, and many efforts have
been made to improve the patient care of LC patients, as well as the development of efficient …

Intercellular cross talk between cancer cells and stromal and immune cells is essential for
tumor progression and metastasis. Extracellular vesicles and particles (EVPs) are a …

The incidence and mortality of lung cancer account for first place all over the world. Lung
cancer lacks early diagnostic biomarkers; lung cancer patients are usually diagnosed in …

Despite the recent progress in cancer management approaches, the mortality rate of cancer
is still growing and there are lots of challenges in the clinics in terms of novel therapeutics …

MicroRNAs (miRNAs) are a group of small non-coding RNAs with approximately 19–25
nucleotides that are involved in regulating a range of developmental and physiological …

Exosomal miRNAs are proposed as excellent candidate biomarkers for clinical applications.
However, little is known about their potential roles as prognostic biomarkers in lung cancer …

In lung cancer and other malignancies, the so-called “liquid biopsy” is quickly moving into
clinical practice. Its full potential has not yet been fully identified, but the “liquid biopsy” is no …

Myeloid‐derived suppressor cells (MDSCs) play a pivotal role in mediating the formation of
an immunosuppressive environment and assisting tumors in evading the host immune …

Exosomes, small extracellular vesicles ranging from 30 to 150 nm, are secreted by various
cell types, including tumour cells. Recently, microRNAs (miRNAs) were identified to be …

Recent studies posit a role for non-coding RNAs in epithelial ovarian cancer (EOC).
Combining small RNA sequencing from 179 human serum samples with a neural network …